Episode 193: Intensive BP lowering, elinzanetant for VMS, HTN in pregnancy and prostate CA screening
Description
Primary care physicians Gary Ferenchick, Kate Rowland, Henry Barry and Mark Ebell want you to know about 4 new studies: the best choice of pharmacotherapy in hypertensive disorders of pregnancy, benefits and harms of intensive BP lowering, elinzanetant for therapy-induced vasomotor symptoms in women with breast cancer, and 23 year follow up of the European Prostate Cancer Screening Trial. Plus a confusing quiz question (thanks Gary!).
Links
Essential Evidence Plus: www.essentialevidenceplus.com
HTN in pregnancy: https://pubmed.ncbi.nlm.nih.gov/40216176/
Intensive BP lowering: https://pubmed.ncbi.nlm.nih.gov/40902616/
Elinzanetant for vasomotor symptoms in patients taking tamoxifen or anastrozole: https://pubmed.ncbi.nlm.nih.gov/40454634/
23 year follow-up of large European prostate cancer study: https://pubmed.ncbi.nlm.nih.gov/41160819/
United States
